Search the Newsreel

Cybin (CYBN) Stock Fair Value Moves Lower As Analysts Rework Psychedelic Sector Assumptions

Cybin's fair value estimate has been reduced by 24% from US$49.46 to US$37.57, reflecting a re-evaluation of the psychedelic sector by analysts. While there's bullish sentiment around large pharma interest in psychedelic agents and impending FDA guidance, bearish sentiment stems from cautious valuation work …

CISO Global puts domains, credentials and certificates in one view

CISO Global has launched SurfaceWatch™, an external cyber exposure platform, through its Argo Security Management™ platform. SurfaceWatch provides continuous monitoring of internet-facing assets, including domains, DNS records, exposed credentials, and SSL/TLS certificates, consolidating findings into a single remediation workflow. This new platform aims to …

CISO Global Launches SurfaceWatch™ to Reveal External Cyber Risks Before They Become Incidents

CISO Global has launched SurfaceWatch™, an AI-powered platform designed to help organizations identify and manage external cyber risks before they escalate into security incidents. The platform offers continuous monitoring of public-facing assets like domains, credentials, and certificates, providing a unified dashboard for risk assessment …

Wells Fargo Initiates Cybin(HELP.US) With Buy Rating, Announces Target Price $16

Wells Fargo has initiated coverage of Cybin (HELP.US) with a Buy rating. The firm has set a target price of $16 for the company's shares. This indicates a positive outlook from Wells Fargo on Cybin's future performance.

CISO|CISO Global Inc|Price:0.261|Chg%:+0.007

This article provides a comprehensive stock analysis of CISO Global Inc (CISO), highlighting its stable fundamentals, significant growth potential, and fair valuation within the Software & IT Services industry. The company, a cybersecurity, compliance, and software firm, has shown weak stock market performance recently …

CISO Financials

This article provides a detailed financial overview of CISO Global Inc. It includes quarterly and annual financial statements such as the income statement, balance sheet, and cash flow statement. Key financial indicators like EPS, Revenue, Net Profit, and various margins are presented with year-on-year …

CISO Global Inc (CISO) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of CISO Global Inc (CISO), listing major shareholders and their proportions, including Hensley & Co, Jemmett Enterprises, L.L.C., and JC Associates Inc. It also provides a breakdown of shareholder types, such as corporations and investment advisors, and institutional …

Cybin Inc. (NASDAQ:HELP) Receives Average Recommendation of "Buy" from Analysts

Five analysts have unanimously given Cybin Inc. (NASDAQ:HELP) a "Buy" rating, with an average 1-year price target of $45.25. Wells Fargo recently initiated coverage with an "overweight" rating and a $16 price objective. The stock saw a 5% increase to $8.00 during Monday trading, …

Cyber Media consolidated net profit rises 46% in Q1FY27

Cybin Ord Shs (HELP) Institutional Confidence

This article from TradingKey focuses on the institutional confidence in Cybin Ord Shs (HELP). It highlights key institutional shareholders and their recent activity, showing significant increases in shares held by top firms like Point72 Asset Management and OrbiMed Advisors. The data provided includes the …

CISO Global Inc (CISO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides an overview of CISO Global Inc (CISO), including its stock performance and market capitalization. It highlights that detailed revenue breakdown data by business segments and regions are not yet disclosed by the company. The page displays placeholders for future …

CISO Global Inc (CISO) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides historical dividend and stock split information for CISO Global Inc (CISO). It indicates that CISO has distributed no dividends over the past five years and details a series of 15-to-1 merger-related stock splits that occurred on March 6, 2024. The stock's …

Cybertech Systems Q1 Results: Unaudited Financials for Q1FY26 Published

Cybertech Systems revenue rises 17.6% in Q1FY27; net profit up 15.9%

HELP|Cybin Ord Shs|Price:7.620|Chg%:-0.110

This page provides a detailed overview of Cybin Ord Shs (HELP), including its current stock price, market capitalization, performance metrics, and key financial figures. It also features analyst ratings, peer comparisons, technical indicators, and major shareholders, alongside frequently asked questions about the company.

CISO Balance Sheet

This article presents the quarterly and annual balance sheets for CISO Global Inc, allowing users to assess the company's financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity. It includes detailed financial figures for assets, liabilities, and shareholders' …

Cybin Inc. Revenue Breakdown – BOATS:HELP

This article provides a basic financial overview of Cybin Inc. (HELP) on the TradingView platform, specifically focusing on its revenue breakdown. It indicates the market status as closed with no trades and highlights functionality for viewing financials, documents, news, and community discussions. The article …

Quantum Cyber N.V. Revenue Breakdown – NASDAQ:QUCY

Built Cybernetics plc Revenue Breakdown – LSE:BUC

CISO Global Inc (CISO) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of CISO Global Inc (CISO), highlighting its current valuation score and P/E ratio within the Software & IT Services industry. The company's valuation score is 8.64, ranking 191 out of 484 in its sector, and its P/E ratio …

Cybertech Systems & Software consolidated net profit rises 16.03% in the June 2026 quarter

Cybin D/B/A Helus Pharma (HELP) Stock Price, News, Quote & History

Cybin D/B/A Helus Pharma (HELP) is a clinical-stage pharmaceutical company focused on developing therapies for psychiatric and neurological conditions. The company's stock is currently trading at $7.62, down 1.42% at close, with a 1-year target estimate of $37.55. Key pipeline assets include HLP003 for …

H.C. Wainwright Maintains Cybin(HELP.US) With Buy Rating, Raises Target Price to $70

H.C. Wainwright has reiterated its Buy rating on Cybin (HELP.US) and increased its price target to $70. This updated guidance reflects a positive outlook from the analyst firm regarding Cybin's future performance.

Chief Financial Officer Greg Cavers Sold A Bunch Of Shares In Cybin

Cybin's Chief Financial Officer, Greg Cavers, recently sold US$431k worth of stock at US$6.10 per share, representing 45% of his holding. This insider sale, occurring below the current market price of US$7.25, raises concerns, although the company's insider ownership at 12% is considered sufficient …

CISO Global Advances AI Software-Led Cybersecurity Strategy with FedRAMP-Certified TiGRIS GRC Platform

CISO Global announced a significant step in its transition to a software-led cybersecurity company by expanding its FedRAMP-certified TiGRIS GRC platform. TiGRIS offers compliance automation, automated evidence collection, and risk-based workflows, with plans to integrate generative AI for enhanced capabilities. This platform, combined with …

CISO Global's TiGRIS Automates Evidence Collection for Compliance

CISO Global (NASDAQ: CISO) announced the expansion of its FedRAMP-certified TiGRIS governance, risk, and compliance (GRC) platform, marking a strategic shift towards AI-powered cybersecurity. TiGRIS centralizes compliance intelligence and automates evidence collection, with plans to integrate generative AI for enhanced analysis and risk visibility. …

CISO Global expands TiGRIS compliance automation platform By Investing.com

CISO Global has announced the expansion of its FedRAMP-certified compliance automation platform, TiGRIS. The platform offers compliance intelligence, automated evidence collection, and risk-based workflows, with plans to integrate generative AI capabilities soon. The company aims to provide more robust governance solutions beyond basic policy …

Cybin (NEOE:HELP) Stock Forecast & Analyst Predictions

Cybin (NEOE:HELP) is forecast to grow earnings by 52.4% and revenue by 63.1% per annum, although analysts no longer expect the company to break even in the foreseeable future, projecting significant losses. Recent developments include the completion of enrollment for a Phase 3 study …

Quantum Cyber Secures Bridgeport Facility for Defense Production

Cybin (HELP) Advances Psychedelic Depression Drug to Phase 3 Amid Fresh Funding – What Really Matters?

Cybin, operating as Helus Pharma, has advanced its lead psychedelic drug candidate HLP003 into a Phase 3 trial for major depressive disorder and recently secured US$50 million in funding. This development is crucial for Cybin's investment narrative, as success in Phase 3 could lead …

Cybin (HELP) Is Up 6.2% After Advancing HLP003 To Phase 3 And Raising US$50 Million

Cybin, operating as Helus Pharma, has advanced its lead psychedelic candidate HLP003 into a Phase 3 trial for major depressive disorder. The company also recently completed an underwritten public offering, raising US$50 million to fund development. This progress positions HLP003 as a potential clinic-based …

Quantum Cyber Acquires Facility Tied to $2.09M in Drone Orders

Quantum Cyber QUCY Stock Pops As Manufacturing, Policy Tailwinds Align

How Quantum Cyber plans to shield 3D‑printed U.S. autonomous drones

CyberTech Systems buyback opens June 4, 2026

Quantum Cyber QUCY Jumps As Autonomous Defense Story Builds